Startups
Invitris

Invitris is a protein-based drugs founded in 2022 by Patrick Grossmann.

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 23,000 COMPANIES →

Summary

Seedtable Score

Score icon 63

Locations

Company Size

  • 1 - 11

Last Stage Round

Industry

Total Funding
$500k
Investors
Full Company Profile